< Back to companies
CIPRA.ai

CIPRA.ai

San Diego, California, United States

CIPRA.ai is the accumulation of eight years of R&D and clinical trials at UC San Diego – supported by Kaiser Permanente, UC San Diego Population Health, Altman Clinical Translational Research Institute, Samsung, Teradata and other industry leaders – which focused on using AI to precisely diagnose and treat patients with chronic conditions. The impetus for this work came from CIPRA.ai's founder Sujit Dey, after a series of self-experiments determined that sleep was the greatest contributor to his hypertension. These findings motivated Sujit to develop a data-driven, intelligent solution to untangle the complex relationships between lifestyle and chronic conditions, as he was joined by former PhD students and co-founders Jared Leitner and PoHan Chiang. Assembling a distinguished team of physicians and experts, the company was launched in July of 2022 and has expanded its AI-based platform to cover chronic hypertension and diabetes, reaching global influence through health system partners

Share
Shareable draft
Get Involved in CIPRA.ai

Company Info

Founded
2022
Website
www.cipra.ai/

Categories

SleepPreventionWellness & Lifestyle

Disease Areas

Technologies

Sleep TrackingWellness PlatformHealth TrackingWearables & Sensors
Only accessible to MedStartr community members. Join now

What do you think of CIPRA.ai?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in CIPRA.ai
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free